Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first‐in‐human phase I study

Documenti analoghi

• Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma
  di: Tomoyuki Satake, et al.
  Pubblicazione: (2025)
• Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor
  di: Maiko Nomoto, et al.
  Pubblicazione: (2024)
• δ¹⁸O and δ¹³C record of Paragloborotalia siakensis and Dentoglobigerina venezuelana from IODP Hole 321-U1337A
  di: Matsui, Hiroki, et al.
  Pubblicazione: (2020)
• Classification of objects in the singularity categories of rational double points in arbitrary characteristics
  di: Takashima, Yuta
  Pubblicazione: (2026)
• Silvofishery: an aquaculture system harmonized with the environment.
  di: Takashima, Fumio
  Pubblicazione: (2000)